Latest News about CVS
Recent news which mentions CVS
From MarketWatch
Fear & Greed Index Remains In 'Fear' Zone Ahead Of Fed's Decision
November 01, 2023
From Benzinga
Kraft Heinz, Yum China And 3 Stocks To Watch Heading Into Wednesday
November 01, 2023
From Benzinga
Strike Alert 2023: Workers at CVS, Walgreens, Rite Aid Walk Out
October 30, 2023
From InvestorPlace
GSK's Competitive Edge, Surpasses Pfizer in Respiratory Syncytial Virus Vaccine Sales
October 30, 2023
From Benzinga
'Pharmageddon' - Thousands Of Pharmacists Plan Walkout To Protest Work Conditions: Report
October 30, 2023
From Benzinga
CVS, Target and other eye-drop products pose risk of dangerous infections, FDA warns
October 30, 2023
From MarketWatch
Risk of Eye Infection - FDA Issues Strong Warning on Eye Drops from Major Retailers
October 30, 2023
From Benzinga
Apple, AMD, Palantir Earnings On Deck This Week As Market Seeks Positive Catalysts In Fed Decision Week
October 30, 2023
From Benzinga
Are Your Eyes At Grave Risk? FDA Issues Dangerous Warning Over Popular Drops From CVS, Target, Cardinal Health And More
October 28, 2023
From Benzinga
Bears Roam Wall Street As Middle East Conflict, Earnings Outlook Raise Concerns Despite Strong Q3 US Economic Growth: This Week In Markets
October 27, 2023
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
October 27, 2023
From Benzinga
Jim Cramer Wants You To 'Stay Away' From This Energy Corporation: 'I've Got So Many Other Good Oil Companies'
October 27, 2023
From Benzinga
2 Absurdly Cheap Healthcare Stocks to Buy and Hold for Decades
October 26, 2023
From Motley Fool
In Need of a Turnaround: Will Walgreens' New CEO Cut or Spare Its High-Yield Dividend?
October 19, 2023
From Motley Fool
From Benzinga
Shares of bankrupt Rite Aid plunge despite meme-stock chatter
October 17, 2023
From MarketWatch
Bitcoin's ETF Approval Rumor, Pfizer Slashes Annual Outlook, Activist Shareholder Shakes Up News Corp's Status Quo: Today's Top Stories
October 16, 2023
From Benzinga
From Benzinga
Novavax (NVAX) Stock Slides Despite Vaccine Availability
October 13, 2023
From InvestorPlace
From InvestorPlace
Jim Carmer Is 'A Seller' Of This Company Because 'Elon Musk Said That He Doesn't Like That Business'
October 11, 2023
From Benzinga
Should You Still Buy the S&P 500's Best-Performing September Stocks?
October 10, 2023
From Motley Fool
Privatized Vaccine Distribution Sparks Confusion, Payment Challenges
October 09, 2023
From Benzinga